Virtual Prescriptions, Real Risks: A Patient's Guide to Safe Telehealth Medication Practices

A Prescription Without a Stethoscope

In 2020, regulatory agencies and health systems across the United States rapidly expanded telehealth permissions in response to the COVID-19 public health emergency. What began as a temporary accommodation has since reshaped how millions of Americans access medical care. Today, a significant portion of non-emergency prescriptions are initiated through video visits, asynchronous messaging platforms, and app-based consultations—often without the patient ever setting foot in a clinical space.

This shift carries genuine benefits. Patients in rural communities, those with limited transportation, and individuals managing chronic conditions that require frequent check-ins have all gained meaningful access to care that was previously out of reach. But the convenience of virtual medicine does not dissolve the clinical realities that physical examinations were designed to address. Understanding where telehealth prescribing is appropriate—and where it carries elevated risk—is essential knowledge for any patient navigating the modern U.S. healthcare landscape.

What a Physical Exam Actually Reveals

It is easy to underestimate what a clinician learns from a hands-on examination. Blood pressure measurement, auscultation of heart and lung sounds, palpation of the abdomen, assessment of lymph nodes, and direct visualization of skin, throat, and eyes are all diagnostic tools that a video camera cannot replicate. These findings frequently inform prescribing decisions in ways that are not captured by a patient's self-reported symptoms.

Consider a patient who contacts a telehealth platform reporting fatigue and requesting a refill of iron supplements or a new prescription for thyroid medication. Without laboratory results and, in some cases, a physical examination, a prescriber cannot reliably differentiate between iron deficiency anemia, hypothyroidism, cardiac insufficiency, or a half-dozen other conditions that share overlapping presentations. A prescription issued in the absence of that diagnostic clarity is, at best, a guess—and at worst, a missed opportunity to identify something serious.

This does not mean telehealth prescribing is inherently irresponsible. It means that responsible telehealth prescribing requires the same diagnostic rigor as in-person care, adapted thoughtfully to the virtual setting.

Medications That Are Generally Appropriate for Telehealth Prescribing

Several categories of medication are widely regarded as suitable for virtual prescribing, provided the clinical encounter is thorough and the patient's history is well-documented.

Maintenance medications for stable chronic conditions — Patients with well-controlled hypertension, type 2 diabetes, or asthma who have an established relationship with a provider and recent laboratory or monitoring data on file are generally good candidates for telehealth prescription renewals.

Oral contraceptives — Multiple studies and clinical guidelines support telehealth prescribing for hormonal contraception when patients complete a structured screening questionnaire and disclose relevant health history. Several U.S. states have formalized this pathway.

Certain dermatological conditions — Acne, rosacea, and mild eczema are among the conditions where high-quality photographs and patient descriptions can provide sufficient clinical information for prescribing topical or systemic treatments.

Mental health medications (with appropriate caveats) — For patients with a documented psychiatric history and established diagnoses, telehealth follow-up for medications such as SSRIs or SNRIs is widely practiced and generally considered safe. New psychiatric evaluations, however, typically benefit from more comprehensive assessment.

Medications That Warrant Caution in Virtual-Only Settings

Not all prescribing decisions are equally suited to remote encounters. The following categories carry elevated risk when prescribed without adequate in-person evaluation:

Controlled substances — The DEA's Ryan Haight Act historically required an in-person evaluation before controlled substances could be prescribed via telemedicine. Temporary pandemic-era waivers relaxed these restrictions, but ongoing regulatory discussions are expected to reimpose some version of the in-person requirement for Schedule II and III substances. Patients receiving stimulants, opioids, or benzodiazepines through telehealth-only platforms should verify that their provider is operating within current federal and state guidelines.

Antibiotics — Prescribing antibiotics without confirmatory testing or physical examination contributes to antimicrobial resistance and can result in inappropriate treatment. A telehealth provider who prescribes a broad-spectrum antibiotic based solely on a patient's description of symptoms—without considering whether a bacterial infection is actually present—is not practicing to the standard of care.

Medications requiring baseline labs or monitoring — Drugs such as metformin (which requires kidney function monitoring), isotretinoin (which mandates participation in a federal risk management program called iPLEDGE), and certain cholesterol-lowering agents should not be initiated without appropriate laboratory evaluation, regardless of the prescribing channel.

Red Flags That Suggest a Substandard Telehealth Provider

The expansion of telehealth has been accompanied by the emergence of platforms that prioritize volume and convenience over clinical rigor. Patients should approach any telehealth prescribing encounter with informed skepticism and watch for the following warning signs:

• No medical history intake or minimal screening — A legitimate telehealth encounter should include a structured review of current medications, allergies, relevant medical history, and the presenting concern.
• Prescriptions issued without a synchronous consultation — Asynchronous platforms that issue prescriptions based solely on a questionnaire, without a real-time conversation with a licensed clinician, fall short of established standards for most prescription decisions.
• Pressure to purchase medications through the platform's own pharmacy — While integrated pharmacy services are not inherently problematic, patients should be cautious of platforms that make it difficult to transfer prescriptions elsewhere or that do not provide a written prescription upon request.
• No follow-up plan or monitoring protocol — Responsible prescribing includes a plan for assessing treatment response and managing potential adverse effects. A provider who issues a prescription with no follow-up recommendation is not providing complete care.
• Unlicensed practitioners or out-of-state prescribing without proper authorization — In the United States, prescribers must be licensed in the state where the patient is located at the time of the telehealth encounter. Patients should confirm their provider's credentials through their state medical board's public verification tool.

Navigating Insurance, Regulation, and Coverage Gaps

Telehealth prescribing exists within a patchwork of state and federal regulations that can affect both the legality of the prescription and the patient's out-of-pocket costs. Medicare, Medicaid, and private insurers vary considerably in how they reimburse telehealth visits and whether telehealth-initiated prescriptions are covered at the same rate as those generated in-person.

Patients should contact their insurer before initiating a telehealth prescribing relationship to understand their coverage terms. Additionally, the end of the federal COVID-19 Public Health Emergency has triggered the expiration of some telehealth flexibilities, and ongoing legislative activity at both the federal and state levels continues to shape what is and is not permissible in virtual prescribing.

Practical Steps for Patients Seeking Remote Prescriptions

For patients who choose to use telehealth services for prescription needs, the following practices support safer outcomes:

1. Bring your complete medication list to every virtual visit, including over-the-counter drugs and supplements.
2. Request documentation of the clinical rationale for any new prescription, particularly if it involves a controlled substance or a medication requiring monitoring.
3. Confirm the provider's license using your state's medical board website before the visit.
4. Ask about follow-up — specifically, how the provider will assess whether the medication is working and what you should do if you experience side effects.
5. Use a consistent provider rather than accessing different telehealth platforms for different needs, which fragments your medical record and increases the risk of drug interactions going undetected.

Telehealth prescribing, practiced responsibly, is a genuine advancement in healthcare access. The key word is responsibly—and patients who understand both the promise and the limitations of virtual care are far better positioned to receive it safely.